ZA9811162B
(en)
*
|
1997-12-12 |
2000-06-07 |
Genentech Inc |
Treatment with anti-ERBB2 antibodies.
|
NZ507557A
(en)
*
|
1998-05-06 |
2003-10-31 |
Genentech Inc |
Protein purification by ion exchange chromatography
|
CA2333747C
(en)
|
1998-06-01 |
2008-02-19 |
Genentech, Inc. |
Separation of protein monomers by use of ion-exchange chromatography
|
US6949245B1
(en)
*
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
US20030086924A1
(en)
*
|
1999-06-25 |
2003-05-08 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
US20040013667A1
(en)
*
|
1999-06-25 |
2004-01-22 |
Genentech, Inc. |
Treatment with anti-ErbB2 antibodies
|
WO2001083781A2
(en)
*
|
2000-04-28 |
2001-11-08 |
Millennium Pharmaceuticals, Inc. |
14094, a novel human trypsin family member and uses thereof
|
US6790709B2
(en)
*
|
2001-11-30 |
2004-09-14 |
Intel Corporation |
Backside metallization on microelectronic dice having beveled sides for effective thermal contact with heat dissipation devices
|
AU2002351353A1
(en)
|
2001-12-19 |
2003-09-02 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
FR2840695B1
(fr)
*
|
2002-06-07 |
2004-10-08 |
Chevrillon Philippe Ind |
Procede de fabrication de ceintures d'impression
|
US7998705B2
(en)
*
|
2002-08-06 |
2011-08-16 |
FUJIFILM Diosynth Biotechnologies U.S.A., Inc |
Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol
|
EP2332996B1
(en)
*
|
2002-09-11 |
2014-10-15 |
Genentech, Inc. |
Purification of anti-Her2 antibodies
|
SI1648998T1
(sl)
*
|
2003-07-18 |
2015-01-30 |
Amgen Inc. |
Specifiäťna vezavna sredstva na hepatocitni rastni faktor
|
US8140164B2
(en)
|
2003-10-15 |
2012-03-20 |
Rmx, Llc |
Therapeutic diaphragm stimulation device and method
|
US8160711B2
(en)
|
2003-10-15 |
2012-04-17 |
Rmx, Llc |
Multimode device and method for controlling breathing
|
US7970475B2
(en)
|
2003-10-15 |
2011-06-28 |
Rmx, Llc |
Device and method for biasing lung volume
|
US9259573B2
(en)
|
2003-10-15 |
2016-02-16 |
Rmx, Llc |
Device and method for manipulating exhalation
|
US8265759B2
(en)
|
2003-10-15 |
2012-09-11 |
Rmx, Llc |
Device and method for treating disorders of the cardiovascular system or heart
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
US8244358B2
(en)
|
2003-10-15 |
2012-08-14 |
Rmx, Llc |
Device and method for treating obstructive sleep apnea
|
US7979128B2
(en)
|
2003-10-15 |
2011-07-12 |
Rmx, Llc |
Device and method for gradually controlling breathing
|
EP1692182B1
(en)
|
2003-11-05 |
2010-04-07 |
Roche Glycart AG |
Cd20 antibodies with increased fc receptor binding affinity and effector function
|
EP1720536B1
(en)
|
2004-02-06 |
2012-04-25 |
PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST |
Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
|
US20060234907A1
(en)
*
|
2004-02-13 |
2006-10-19 |
Werner Gehringer |
Albumin solution and process for the production thereof
|
US7713629B2
(en)
*
|
2004-03-26 |
2010-05-11 |
Florida State University Research Foundation |
Hydrophobic fluorinated polyelectrolyte complex films and associated methods
|
US9056125B2
(en)
|
2004-05-17 |
2015-06-16 |
Florida State University Research Foundation, Inc. |
Films for controlled cell growth and adhesion
|
SV2006002143A
(es)
*
|
2004-06-16 |
2006-01-26 |
Genentech Inc |
Uso de un anticuerpo para el tratamiento del cancer resistente al platino
|
KR20180091967A
(ko)
|
2004-07-22 |
2018-08-16 |
제넨테크, 인크. |
Her2 항체 조성물
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
EP1825001A2
(en)
*
|
2004-12-07 |
2007-08-29 |
Genentech, Inc. |
Selecting patients for therapy with a her inhibitor
|
CN101141981A
(zh)
|
2005-01-21 |
2008-03-12 |
健泰科生物技术公司 |
Her抗体的固定剂量给药
|
KR20070100968A
(ko)
*
|
2005-02-09 |
2007-10-15 |
제넨테크, 인크. |
매트릭스 메탈로프로테아제 길항제를 사용한, her2박리의 억제
|
DK1850874T3
(da)
|
2005-02-23 |
2013-11-11 |
Genentech Inc |
Forlængelse af tid til sygdomsprogression eller overlevelse for ovariecancer ved anvendelse af pertuzumab
|
US7585955B2
(en)
*
|
2005-03-03 |
2009-09-08 |
Florida State University Research Foundation, Inc |
Protein separation from a protein mixture
|
WO2006096861A2
(en)
*
|
2005-03-08 |
2006-09-14 |
Genentech, Inc. |
METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs)
|
US7459542B2
(en)
*
|
2005-03-10 |
2008-12-02 |
Florida State University Research Foundation, Inc. |
Separation of albumin from protein samples
|
JP2006316040A
(ja)
|
2005-05-13 |
2006-11-24 |
Genentech Inc |
Herceptin(登録商標)補助療法
|
TWI320788B
(en)
†
|
2005-05-25 |
2010-02-21 |
Hoffmann La Roche |
Method for the purification of antibodies
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
US8921344B2
(en)
|
2006-11-03 |
2014-12-30 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
RU2466740C2
(ru)
|
2006-04-05 |
2012-11-20 |
Эбботт Байотекнолоджи Лтд. |
Очистка антитела
|
AU2007321877B2
(en)
*
|
2006-08-01 |
2011-11-03 |
Kineta Two, Llc |
Pharmaceutical manufacturing methods
|
CA2661872A1
(en)
*
|
2006-08-28 |
2008-03-06 |
Ares Trading S.A. |
Process for the purification of fc-fusion proteins
|
ES2755386T5
(es)
|
2006-08-28 |
2023-04-05 |
Ares Trading Sa |
Proceso para la purificación de proteínas que contienen fragmentos Fc
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
CN103555652A
(zh)
|
2006-09-13 |
2014-02-05 |
Abbvie公司 |
细胞培养改良
|
US8280513B2
(en)
|
2006-12-22 |
2012-10-02 |
Rmx, Llc |
Device and method to treat flow limitations
|
US7947813B2
(en)
*
|
2007-01-22 |
2011-05-24 |
Genentech, Inc. |
Polyelectrolyte precipitation and purification of proteins
|
KR20090115980A
(ko)
|
2007-03-02 |
2009-11-10 |
제넨테크, 인크. |
낮은 her3 발현을 기초로 한 her 이량체화 억제제에 대한 반응 예측
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
CA2687837A1
(en)
*
|
2007-06-01 |
2008-12-04 |
F. Hoffmann-La Roche Ag |
Immunoglobulin purification
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
ES2417148T3
(es)
|
2007-06-08 |
2013-08-06 |
Genentech, Inc. |
Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
|
ES2666170T3
(es)
*
|
2007-10-30 |
2018-05-03 |
Genentech, Inc. |
Purificación de anticuerpos mediante cromatografía de intercambio catiónico
|
AU2012227163B2
(en)
*
|
2007-10-30 |
2015-07-16 |
Genentech, Inc. |
Antibody purification by cation exchange chromatography
|
US8454960B2
(en)
|
2008-01-03 |
2013-06-04 |
The Scripps Research Institute |
Multispecific antibody targeting and multivalency through modular recognition domains
|
US8557242B2
(en)
|
2008-01-03 |
2013-10-15 |
The Scripps Research Institute |
ERBB2 antibodies comprising modular recognition domains
|
US8557243B2
(en)
|
2008-01-03 |
2013-10-15 |
The Scripps Research Institute |
EFGR antibodies comprising modular recognition domains
|
US8574577B2
(en)
|
2008-01-03 |
2013-11-05 |
The Scripps Research Institute |
VEGF antibodies comprising modular recognition domains
|
KR101658247B1
(ko)
|
2008-01-03 |
2016-09-22 |
더 스크립스 리서치 인스티튜트 |
모듈 인식 도메인을 통한 항체 표적화
|
TWI472339B
(zh)
|
2008-01-30 |
2015-02-11 |
Genentech Inc |
包含結合至her2結構域ii之抗體及其酸性變異體的組合物
|
KR20210131473A
(ko)
|
2008-03-18 |
2021-11-02 |
제넨테크, 인크. |
항-her2 항체-약물 접합체와 화학요법제의 병용물, 및 사용 방법
|
KR20110014607A
(ko)
|
2008-04-29 |
2011-02-11 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
CN102112494A
(zh)
|
2008-06-03 |
2011-06-29 |
雅培制药有限公司 |
双重可变结构域免疫球蛋白及其用途
|
WO2009149189A2
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
JP5986745B2
(ja)
|
2008-07-15 |
2016-09-06 |
アカデミア シニカAcademia Sinica |
Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
|
KR102196883B1
(ko)
*
|
2008-08-14 |
2020-12-30 |
제넨테크, 인크. |
고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법
|
TW201014605A
(en)
|
2008-09-16 |
2010-04-16 |
Genentech Inc |
Methods for treating progressive multiple sclerosis
|
AU2008221604B2
(en)
*
|
2008-09-22 |
2010-04-22 |
Commonwealth Scientific And Industrial Research Organisation |
Temperature-responsive polymer particles in protein separation applications
|
JP5913980B2
(ja)
|
2008-10-14 |
2016-05-11 |
ジェネンテック, インコーポレイテッド |
免疫グロブリン変異体及びその用途
|
TWI610936B
(zh)
*
|
2008-10-20 |
2018-01-11 |
艾伯維有限公司 |
使用蛋白質a親和性層析進行抗體之分離及純化
|
CA2738499A1
(en)
|
2008-10-20 |
2010-04-29 |
Abbott Laboratories |
Viral inactivation during purification of antibodies
|
CN102272154A
(zh)
*
|
2008-10-29 |
2011-12-07 |
惠氏有限责任公司 |
单域抗原结合性分子的纯化方法
|
US20110313137A1
(en)
*
|
2009-02-25 |
2011-12-22 |
Dongxing Zha |
Her2 antibody compositions
|
AU2010226453B2
(en)
|
2009-03-20 |
2013-11-21 |
Genentech, Inc. |
Bispecific anti-HER antibodies
|
CA2759502C
(en)
*
|
2009-04-29 |
2021-02-09 |
Bio-Rad Laboratories, Inc. |
Purification of immunoconjugates
|
SG176073A1
(en)
|
2009-05-29 |
2011-12-29 |
Hoffmann La Roche |
Modulators for her2 signaling in her2 expressing patients with gastric cancer
|
US20120177640A1
(en)
|
2009-07-24 |
2012-07-12 |
Josef Burg |
Optimizing the production of antibodies
|
JP5921433B2
(ja)
|
2009-07-24 |
2016-05-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
攪拌システム
|
US9345661B2
(en)
|
2009-07-31 |
2016-05-24 |
Genentech, Inc. |
Subcutaneous anti-HER2 antibody formulations and uses thereof
|
PL2467399T3
(pl)
*
|
2009-08-20 |
2016-05-31 |
Baxalta Inc |
Oczyszczanie vWF zwiększające usuwanie wirusów bez otoczki lipidowej
|
JP2013503607A
(ja)
|
2009-09-01 |
2013-02-04 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびその使用
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
KR101508044B1
(ko)
|
2009-10-01 |
2015-04-07 |
에프. 호프만-라 로슈 아게 |
다단계 최종 여과
|
RU2012119756A
(ru)
|
2009-10-15 |
2013-11-20 |
Эбботт Лэборетриз |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US8304248B2
(en)
*
|
2009-11-16 |
2012-11-06 |
Torres Anthony R |
Protein separation via ion-exchange chromatography and associated methods, systems, and devices
|
US8697844B2
(en)
*
|
2009-11-24 |
2014-04-15 |
Novo Nordisk A/S |
Method of purifying pegylated proteins
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
JP6184695B2
(ja)
|
2009-12-04 |
2017-08-23 |
ジェネンテック, インコーポレイテッド |
多重特異性抗体、抗体アナログ、組成物、及び方法
|
US20110165155A1
(en)
*
|
2009-12-04 |
2011-07-07 |
Genentech, Inc. |
Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1
|
WO2011073389A1
(en)
|
2009-12-18 |
2011-06-23 |
Novartis Ag |
Wash solution and method for affinity chromatography
|
EP2536748B1
(en)
|
2010-02-18 |
2014-08-20 |
Genentech, Inc. |
Neuregulin antagonists and use thereof in treating cancer
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
KR101152036B1
(ko)
|
2010-04-27 |
2012-06-08 |
(주)셀트리온 |
컬럼 순환 및 시료 연속주입법을 이용한 단백질 a 크로마토그래피 정제 방법
|
US9403855B2
(en)
|
2010-05-10 |
2016-08-02 |
Academia Sinica |
Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
|
CA2799502A1
(en)
*
|
2010-05-18 |
2011-11-24 |
Abbvie Inc. |
Apparatus and process for purification of proteins
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
MY161534A
(en)
*
|
2010-05-25 |
2017-04-28 |
Genentech Inc |
Methods of purifying polypeptides
|
RU2604811C2
(ru)
*
|
2010-05-27 |
2016-12-10 |
Мерк Шарп Энд Домэ Корп. |
Способ получения антител с улучшенными свойствами
|
US20120100166A1
(en)
|
2010-07-15 |
2012-04-26 |
Zyngenia, Inc. |
Ang-2 Binding Complexes and Uses Thereof
|
GB201012603D0
(en)
|
2010-07-27 |
2010-09-08 |
Ucb Pharma Sa |
Protein purification
|
EP3252072A3
(en)
|
2010-08-03 |
2018-03-14 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
NZ604510A
(en)
|
2010-08-17 |
2013-10-25 |
Csl Ltd |
Dilutable biocidal compositions and methods of use
|
WO2012027570A2
(en)
|
2010-08-26 |
2012-03-01 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
JPWO2012029990A1
(ja)
*
|
2010-09-01 |
2013-10-31 |
株式会社バイオマトリックス研究所 |
大腸がんマーカーに対する抗体
|
PE20131411A1
(es)
|
2010-10-05 |
2013-12-16 |
Hoffmann La Roche |
Anticuerpos contra la tweak humana y usos de los mismos
|
TW201221641A
(en)
*
|
2010-10-11 |
2012-06-01 |
Abbott Lab |
Processes for purification of proteins
|
EP2643353A1
(en)
|
2010-11-24 |
2013-10-02 |
Novartis AG |
Multispecific molecules
|
CN103429609A
(zh)
*
|
2010-12-08 |
2013-12-04 |
安姆根有限公司 |
在氨基酸存在下的离子交换层析
|
CA2820095C
(en)
|
2010-12-21 |
2019-02-26 |
F. Hoffmann-La Roche Ag |
Isoform enriched antibody preparation and method for obtaining it
|
SG191153A1
(en)
|
2010-12-23 |
2013-07-31 |
Hoffmann La Roche |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
US9181325B2
(en)
*
|
2011-03-03 |
2015-11-10 |
Arla Foods Amba |
Method for isolating osteopontin using concentrated feeds
|
WO2012122590A1
(en)
|
2011-03-14 |
2012-09-20 |
Cellmid Limited |
Antibody recognizing n-domain of midkine
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
WO2012162561A2
(en)
|
2011-05-24 |
2012-11-29 |
Zyngenia, Inc. |
Multivalent and monovalent multispecific complexes and their uses
|
EP2718326B1
(en)
|
2011-06-13 |
2020-08-19 |
CSL Limited |
Antibodies against g-csfr and uses thereof
|
KR20140057326A
(ko)
|
2011-08-17 |
2014-05-12 |
제넨테크, 인크. |
뉴레귤린 항체 및 그의 용도
|
WO2013050335A1
(en)
|
2011-10-05 |
2013-04-11 |
F. Hoffmann-La Roche Ag |
Process for antibody g1 glycoform production
|
KR20230028585A
(ko)
|
2011-10-14 |
2023-02-28 |
제넨테크, 인크. |
Her2 이량체화 억제제인 페르투주맙의 용도 및 이를 포함하는 제조품
|
US9327023B2
(en)
|
2011-10-25 |
2016-05-03 |
The Regents Of The University Of Michigan |
HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells
|
EP2771351B1
(en)
|
2011-10-28 |
2017-06-14 |
Patrys Limited |
Pat-lm1 epitopes and methods for using same
|
WO2013066707A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Chromatography process for resolving heterogeneous antibody aggregates
|
SI2773438T2
(sl)
*
|
2011-11-02 |
2022-05-31 |
F.Hoffmann-La Roche Ag |
Izpiralna kromatografija s preobremenitvijo
|
US20130195870A1
(en)
|
2011-11-30 |
2013-08-01 |
Genentech, Inc. |
ERBB3 Mutations In Cancer
|
WO2013083810A1
(en)
|
2011-12-09 |
2013-06-13 |
F. Hoffmann-La Roche Ag |
Identification of non-responders to her2 inhibitors
|
US20130195851A1
(en)
|
2011-12-23 |
2013-08-01 |
Genentech, Inc. |
Articles of manufacture and methods for co-administration of antibodies
|
JP2015508994A
(ja)
|
2011-12-30 |
2015-03-26 |
アッヴィ・インコーポレイテッド |
Il−13および/またはil−17に対する二重可変ドメイン免疫グロブリン
|
JP2015514710A
(ja)
|
2012-03-27 |
2015-05-21 |
ジェネンテック, インコーポレイテッド |
Her3阻害剤に関する診断及び治療
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
US9505833B2
(en)
|
2012-04-20 |
2016-11-29 |
Abbvie Inc. |
Human antibodies that bind human TNF-alpha and methods of preparing the same
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
EP3505534A1
(en)
|
2012-06-08 |
2019-07-03 |
Sutro Biopharma, Inc. |
Antibodies comprising sitespecific nonnatural amino acid residues, methods of their preparation and methods of their use
|
US9732161B2
(en)
*
|
2012-06-26 |
2017-08-15 |
Sutro Biopharma, Inc. |
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
JP6302909B2
(ja)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
シアリダーゼの同定および画像化のための細胞透過性プローブ
|
EP2888238A4
(en)
|
2012-08-21 |
2016-01-27 |
Academia Sinica |
BENZOCYCLO-OCTYNE COMPOUNDS AND USES THEREOF
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
AU2013309506A1
(en)
|
2012-09-02 |
2015-03-12 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
EP2914625A2
(en)
|
2012-11-01 |
2015-09-09 |
AbbVie Inc. |
Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
|
WO2014083178A1
(en)
|
2012-11-30 |
2014-06-05 |
F. Hoffmann-La Roche Ag |
Identification of patients in need of pd-l1 inhibitor cotherapy
|
WO2014118685A2
(en)
*
|
2013-01-29 |
2014-08-07 |
Dr. Reddy's Laboratories Limited |
Method of altering the acidic variant content of antibody
|
EP4219552A3
(en)
|
2013-02-07 |
2023-09-13 |
CSL Ltd. |
Il-11r binding proteins and uses thereof
|
AU2014226126B2
(en)
|
2013-03-08 |
2019-02-14 |
Genzyme Corporation |
Continuous purification of therapeutic proteins
|
US10023608B1
(en)
|
2013-03-13 |
2018-07-17 |
Amgen Inc. |
Protein purification methods to remove impurities
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
SG11201505901YA
(en)
|
2013-03-14 |
2015-08-28 |
Emd Millipore Corp |
Methods of increasing protein purity using protein a based chromatography
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
US9499614B2
(en)
|
2013-03-14 |
2016-11-22 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
|
US9062108B2
(en)
|
2013-03-15 |
2015-06-23 |
Abbvie Inc. |
Dual specific binding proteins directed against IL-1 and/or IL-17
|
EA038918B1
(ru)
|
2013-03-15 |
2021-11-09 |
Зинджения, Инк. |
Пептид, связывающий рецептор эпидермального фактора роста, мультиспецифические комплексы, содержащие пептид и антитела, и их применение
|
BR112015024926A2
(pt)
|
2013-04-16 |
2017-10-10 |
Genentech Inc |
composições, artigo de fabricação, métodos para tratar um paciente com câncer, para avaliar uma composição, para avaliar a atividade biológica, para produzir uma composição e para avaliar a fragmentação de uma composição e variante de pertuzumabe
|
TWI596107B
(zh)
|
2013-06-25 |
2017-08-21 |
卡地拉保健有限公司 |
單株抗體之新穎純化方法
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
EP3013347B1
(en)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glycan conjugates and use thereof
|
US9764039B2
(en)
*
|
2013-07-10 |
2017-09-19 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
JP6462681B2
(ja)
|
2013-07-12 |
2019-01-30 |
ジェネンテック, インコーポレイテッド |
イオン交換クロマトグラフィーのインプットの最適化の解明
|
EP3041484B1
(en)
|
2013-09-06 |
2021-03-03 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
US10519195B2
(en)
*
|
2013-09-17 |
2019-12-31 |
Kaneka Corporation |
Antibody purification method, antibody obtained therefrom, novel antibody purification method using cation exchanger, and antibody obtained therefrom
|
WO2015051293A2
(en)
|
2013-10-04 |
2015-04-09 |
Abbvie, Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
SG11201603028SA
(en)
*
|
2013-10-18 |
2016-05-30 |
Universität Für Bodenkultur Wien |
Purification of proteins
|
US10351592B2
(en)
*
|
2013-10-30 |
2019-07-16 |
Celltrion, Inc. |
Method for separating antibody isoforms using cation exchange chromatography
|
CN104628846B
(zh)
*
|
2013-11-06 |
2019-12-06 |
三生国健药业(上海)股份有限公司 |
重组蛋白质的纯化方法
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
CA2937123A1
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
TWI709569B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析樹脂及其用於製造方法的用途
|
TWI709570B
(zh)
|
2014-01-17 |
2020-11-11 |
美商健臻公司 |
無菌層析法及製法
|
EP3129767B1
(en)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
EP3134440A1
(en)
|
2014-04-25 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Methods of treating early breast cancer with trastuzumab-mcc-dm1 and pertuzumab
|
KR20170005142A
(ko)
|
2014-05-27 |
2017-01-11 |
아카데미아 시니카 |
증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
EP3149037A4
(en)
|
2014-05-27 |
2018-01-10 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
KR20170003720A
(ko)
|
2014-05-27 |
2017-01-09 |
아카데미아 시니카 |
항-cd20 글리코항체 및 이의 용도
|
TWI732738B
(zh)
|
2014-05-28 |
2021-07-11 |
中央研究院 |
抗TNF-α醣抗體及其用途
|
AU2015279831A1
(en)
*
|
2014-06-25 |
2017-01-12 |
Jhl Biotech, Inc. |
Methods and reagents for purification of proteins
|
CN105315369B
(zh)
*
|
2014-07-25 |
2020-03-13 |
山东博安生物技术有限公司 |
利用阳离子交换层析纯化蛋白质
|
WO2016033245A1
(en)
|
2014-08-26 |
2016-03-03 |
Rmx, Llc |
Devices and methods for reducing intrathoracic pressure
|
KR102422375B1
(ko)
|
2014-09-08 |
2022-07-18 |
아카데미아 시니카 |
당지질을 사용한 인간 iNKT 세포 활성화
|
WO2016037947A1
(en)
|
2014-09-10 |
2016-03-17 |
F. Hoffmann-La Roche Ag |
Galactoengineered immunoglobulin 1 antibodies
|
JP2021006540A
(ja)
*
|
2014-09-10 |
2021-01-21 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ガラクトース操作型免疫グロブリン1抗体
|
SG10201809668TA
(en)
|
2014-09-12 |
2018-11-29 |
Genentech Inc |
Anti-her2 antibodies and immunoconjugates
|
RU2727663C2
(ru)
|
2014-09-17 |
2020-07-22 |
Дженентек, Инк. |
Иммуноконъюгаты, содержащие антитела против her2 и пирролбензодиазепины
|
WO2016061632A1
(en)
|
2014-10-23 |
2016-04-28 |
La Trobe University |
Fn14-binding proteins and uses thereof
|
MX2017005148A
(es)
|
2014-11-06 |
2017-08-08 |
Hoffmann La Roche |
Variantes de region fc con union del receptor fc neonatal (fcrn) modificado y metodos de uso.
|
KR101531479B1
(ko)
*
|
2014-11-21 |
2015-06-26 |
세원셀론텍(주) |
의료용 재료로 사용하기 위한 고농도 콜라겐 제조방법
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
WO2016094962A1
(en)
|
2014-12-19 |
2016-06-23 |
Monash University |
Il-21 antibodies
|
CN110658340B
(zh)
*
|
2015-01-08 |
2023-10-31 |
苏州康宁杰瑞生物科技有限公司 |
具有共同轻链的双特异性抗体或抗体混合物
|
CA2973317A1
(en)
|
2015-01-09 |
2016-07-14 |
Adalta Pty Ltd |
Cxcr4 binding molecules
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US10696735B2
(en)
*
|
2015-01-21 |
2020-06-30 |
Outlook Therapeutics, Inc. |
Modulation of charge variants in a monoclonal antibody composition
|
WO2016118191A1
(en)
|
2015-01-24 |
2016-07-28 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
AU2016233557B2
(en)
*
|
2015-03-13 |
2021-06-24 |
Bristol-Myers Squibb Company |
Use of alkaline washes during chromatography to remove impurities
|
CN107614015A
(zh)
|
2015-05-30 |
2018-01-19 |
豪夫迈·罗氏有限公司 |
治疗her2阳性局部晚期或先前未治疗的转移性乳腺癌的方法
|
CN108064246A
(zh)
|
2015-06-15 |
2018-05-22 |
基因泰克公司 |
抗体和免疫结合物
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
PL3319995T3
(pl)
|
2015-07-07 |
2019-09-30 |
F. Hoffmann-La Roche Ag |
Terapia skojarzona z użyciem koniugatu przeciwciało anty-her2-lek i inhibitora bcl-2
|
WO2017087280A1
(en)
|
2015-11-16 |
2017-05-26 |
Genentech, Inc. |
Methods of treating her2-positive cancer
|
US20180327447A1
(en)
*
|
2015-11-18 |
2018-11-15 |
Merck Patent Gmbh |
Improved protein separation in ion exchange chromatography
|
AU2016356482A1
(en)
*
|
2015-11-18 |
2018-06-28 |
Merck Patent Gmbh |
Opposite pH-salt gradients for improved protein separations
|
CA3011455A1
(en)
|
2016-01-27 |
2017-08-03 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
JP7084308B2
(ja)
|
2016-02-03 |
2022-06-14 |
アウトルック セラピューティクス,インコーポレイティド |
抗体安定性を増大させるための緩衝液製剤
|
US10336784B2
(en)
|
2016-03-08 |
2019-07-02 |
Academia Sinica |
Methods for modular synthesis of N-glycans and arrays thereof
|
US20190151346A1
(en)
|
2016-05-10 |
2019-05-23 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Combinations therapies for the treatment of cancer
|
KR102470282B1
(ko)
|
2016-07-15 |
2022-11-24 |
에프. 호프만-라 로슈 아게 |
Peg화 에리트로포이에틴을 정제하기 위한 방법
|
US10538592B2
(en)
|
2016-08-22 |
2020-01-21 |
Cho Pharma, Inc. |
Antibodies, binding fragments, and methods of use
|
BR112019006074A2
(pt)
|
2016-09-29 |
2019-06-18 |
Beijing Hanmi Pharmaceutical Co Ltd |
heterodímero, método de produção do heterodímero, métodos de produção de um heterodímero, ácido nucleico, vetor ou sistema de vetores, célula, composição farmacêutica e método de tratamento ou prevenção de uma doença ou distúrbio em um sujeito em necessidade do mesmo
|
JP2019532999A
(ja)
|
2016-11-04 |
2019-11-14 |
ジェネンテック, インコーポレイテッド |
Her2陽性乳がんの治療
|
EP3533804A4
(en)
*
|
2016-11-18 |
2020-06-17 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
BISPECIFIC ANTIBODY TYPE ANTI-PD -1 / ANTI-HER2 NATURAL ANTIBODY HETERODIMERIC FORM AND PREPARATION THEREOF
|
KR102313262B1
(ko)
|
2016-12-28 |
2021-10-14 |
제넨테크, 인크. |
진행성 her2 발현 암의 치료
|
JP6741875B2
(ja)
|
2017-01-17 |
2020-08-19 |
ジェネンテック, インコーポレイテッド |
皮下her2抗体製剤
|
KR102417583B1
(ko)
|
2017-03-02 |
2022-07-07 |
제넨테크, 인크. |
Her2-양성 유방암 어쥬번트 치료
|
KR20190140952A
(ko)
|
2017-04-24 |
2019-12-20 |
제넨테크, 인크. |
막관통 및 인접막 도메인에서의 erbb2/her2 돌연변이
|
CN107602702A
(zh)
*
|
2017-09-22 |
2018-01-19 |
生标(上海)医疗器械科技有限公司 |
一种同时靶向人p185和血管内皮生长因子的抗体及其应用
|
CN108101987A
(zh)
*
|
2017-11-17 |
2018-06-01 |
安徽未名生物医药有限公司 |
一种重组抗TNF-α全人源单克隆抗体的纯化方法
|
DK3717011T3
(da)
|
2017-11-29 |
2023-01-09 |
Csl Ltd |
Fremgangsmåde til behandling eller forebyggelse af iskæmi-reperfusionsskade
|
WO2019153200A1
(zh)
|
2018-02-08 |
2019-08-15 |
北京韩美药品有限公司 |
抗pd-1/抗her2天然抗体结构样异源二聚体形式双特异抗体及其制备
|
TW202003561A
(zh)
|
2018-03-13 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
使用靶向4-1bb (cd137)之促效劑的組合療法
|
EA202092335A1
(ru)
|
2018-04-02 |
2021-01-22 |
Эмджен Инк. |
Композиции на основе эренумаба и пути их применения
|
CA3094235A1
(en)
|
2018-04-13 |
2019-10-17 |
F. Hoffmann-La Roche Ag |
Her2-targeting antigen binding molecules comprising 4-1bbl
|
US20210340279A1
(en)
|
2018-08-31 |
2021-11-04 |
Yale University |
Compositions and methods of using cell-penetrating antibodies in combination with immune checkpoint modulators
|
KR20210049155A
(ko)
|
2018-08-31 |
2021-05-04 |
젠자임 코포레이션 |
멸균 크로마토그래피 수지 및 제조 공정에서 이의 용도
|
AU2019361871B2
(en)
|
2018-10-15 |
2023-08-10 |
Genentech, Inc. |
Methods of treating residual breast cancer with trastuzumab emtansine
|
CN111196856A
(zh)
*
|
2018-11-19 |
2020-05-26 |
三生国健药业(上海)股份有限公司 |
抗her2/pd1双特异性抗体
|
CN113677403A
(zh)
|
2019-04-12 |
2021-11-19 |
豪夫迈·罗氏有限公司 |
包含脂质运载蛋白突变蛋白的双特异性抗原结合分子
|
WO2020234742A1
(en)
|
2019-05-20 |
2020-11-26 |
Lupin Limited |
Granulocyte colony stimulating factor purification
|
KR20220034784A
(ko)
|
2019-06-13 |
2022-03-18 |
볼트 바이오테라퓨틱스 인코퍼레이티드 |
아미노벤즈아제핀 화합물, 면역접합체, 및 이의 용도
|
US11266838B1
(en)
|
2019-06-21 |
2022-03-08 |
Rmx, Llc |
Airway diagnostics utilizing phrenic nerve stimulation device and method
|
CN110339209B
(zh)
*
|
2019-07-18 |
2023-06-06 |
上海泰坦科技股份有限公司 |
一种去甲状腺结合蛋白的小牛血清的制备方法
|
JP2022546110A
(ja)
|
2019-09-03 |
2022-11-02 |
ボルト バイオセラピューティクス、インコーポレーテッド |
アミノキノリン化合物、免疫複合体、及びそれらの使用
|
AU2020359446A1
(en)
|
2019-09-30 |
2022-04-21 |
Bolt Biotherapeutics, Inc. |
Amide-linked, aminobenzazepine immunoconjugates, and uses thereof
|
WO2021076489A1
(en)
*
|
2019-10-14 |
2021-04-22 |
Pierce Biotechnology, Inc. |
Peptide purification formulations and methods
|
MX2022004875A
(es)
|
2019-10-25 |
2022-06-17 |
Bolt Biotherapeutics Inc |
Inmunoconjugados de tienoazepina, inmunoconjugados y usos de estos.
|
WO2021097220A1
(en)
|
2019-11-15 |
2021-05-20 |
Seagen Inc. |
Methods of treating her2 positive breast cancer with tucatinib in combination with an anti-her2 antibody-drug conjugate
|
US11725048B2
(en)
|
2019-12-20 |
2023-08-15 |
Hudson Institute of Medical Research |
CXCL10 binding proteins and compositions thereof
|
WO2021226440A1
(en)
|
2020-05-08 |
2021-11-11 |
Bolt Biotherapeutics, Inc. |
Elastase-substrate, peptide linker immunoconjugates, and uses thereof
|
MX2022015795A
(es)
|
2020-06-23 |
2023-01-24 |
Hoffmann La Roche |
Moleculas agonistas de union al antigeno cd28 que se dirigen a her2.
|
KR20230030621A
(ko)
|
2020-06-29 |
2023-03-06 |
제넨테크, 인크. |
퍼투주맙 + 트라스투주맙 고정 용량 조합
|
IL299121A
(en)
|
2020-07-14 |
2023-02-01 |
Hoffmann La Roche |
Tests for fixed dose combinations
|
EP4182475A2
(en)
|
2020-07-17 |
2023-05-24 |
Onena Medicines S.L. |
Antibodies against lefty proteins
|
EP4196168A1
(en)
|
2020-08-13 |
2023-06-21 |
Bolt Biotherapeutics, Inc. |
Pyrazoloazepine immunoconjugates, and uses thereof
|
CN112430252B
(zh)
*
|
2020-11-13 |
2022-09-02 |
宜昌东阳光长江药业股份有限公司 |
一种提高目标蛋白回收率的层析方法
|
EP4259662A1
(en)
|
2020-12-11 |
2023-10-18 |
Genentech, Inc. |
Combination therapies for treatment of her2 cancer
|
EP4259211A1
(en)
|
2020-12-11 |
2023-10-18 |
Bolt Biotherapeutics, Inc. |
Anti-her2 immunoconjugates, and uses thereof
|
WO2022125904A1
(en)
|
2020-12-11 |
2022-06-16 |
Bolt Biotherapeutics, Inc. |
Anti-her2 immunoconjugates, and uses thereof
|
EP4313162A1
(en)
|
2021-03-26 |
2024-02-07 |
Bolt Biotherapeutics, Inc. |
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
|
EP4313161A1
(en)
|
2021-03-26 |
2024-02-07 |
Bolt Biotherapeutics, Inc. |
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
|
TW202304949A
(zh)
|
2021-04-01 |
2023-02-01 |
美商韋斯塔隆公司 |
用於害蟲防治之av3突變多肽
|
CN113769794B
(zh)
*
|
2021-07-06 |
2024-04-05 |
沁浩膜技术(厦门)有限公司 |
一种连续脱除胞磷胆碱钠中杂质的离子交换系统及方法
|
WO2023076599A1
(en)
|
2021-10-29 |
2023-05-04 |
Bolt Biotherapeutics, Inc. |
Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof
|
WO2023122805A1
(en)
|
2021-12-20 |
2023-06-29 |
Vestaron Corporation |
Sorbitol driven selection pressure method
|
CN114230641B
(zh)
*
|
2021-12-29 |
2024-03-26 |
内蒙古必威安泰生物科技有限公司 |
一种去除口蹄疫抗原液中内毒素的方法
|
WO2023192924A1
(en)
|
2022-03-30 |
2023-10-05 |
Vestaron Corporation |
Combinations of av3 mutant polypeptides and bt toxins for pest control
|
WO2023225555A1
(en)
|
2022-05-18 |
2023-11-23 |
Vestaron Corporation |
Pesticidal actx peptide variants
|
WO2023245100A1
(en)
|
2022-06-17 |
2023-12-21 |
Vestaron Corporation |
Antimicrobial ncr13 variant peptides
|
WO2024026406A2
(en)
|
2022-07-29 |
2024-02-01 |
Vestaron Corporation |
Next Generation ACTX Peptides
|
WO2024038193A1
(en)
|
2022-08-18 |
2024-02-22 |
Immunocore Limited |
Multi-domain binding molecules
|
WO2024038198A1
(en)
|
2022-08-18 |
2024-02-22 |
Immunocore Limited |
Multi-domain binding molecules
|
WO2024038183A1
(en)
|
2022-08-18 |
2024-02-22 |
Immunocore Limited |
Multi-domain binding molecules
|